Determinants of participation in colorectal cancer screening with faecal occult blood testing

Journal of Public Health

Volumn 32, Issue 3, 2010, Pages 395-405

  Von Euler Chelpin, My ^a   Brasso, Klaus ^b   Lynge, Elsebeth ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Research Centre for Prevention and Health   (Denmark)

Author keywords

cancer; screening; socio economics factors

Indexed keywords

ADULT; AGED; ARTICLE; COLORECTAL TUMOR; FEMALE; HUMAN; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PATIENT ATTITUDE; UTILIZATION REVIEW;

ADULT; AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PATIENT ACCEPTANCE OF HEALTH CARE;

EID: 77956048651     PISSN: 17413842     EISSN: 17413850     Source Type: Journal    
DOI: 10.1093/pubmed/fdp115     Document Type: Article

References (54)

1. Descriptive Epidemiology Groups of IARC. . fr/ (11 April 2008, date last accessed).
2. Boyle P, Vainio H, Smith R et al. Workgroup I: criteria for screening. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002). Ann Oncol 2005;16(1):25-30.
3. Hardcastle JD, Chamberlain JO, Robinson MH et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348(9040):1472-1477
4. Kronborg O, Fenger C, Olsen J et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348(9040):1467-1471
5. World Gastroenterology Organisation, International Digestive Cancer Alliance. Practice Guidelines: Colorectal cancer screening. World Gastroenterology Organisation, 2007.
6. Mandel JS, Bond JH, Church TR et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328(19):1365-1371
7. Kronborg O, Jorgensen OD, Fenger C et al. Randomized study of biennial screening with a faecal occult blood test: results after nine screening rounds. Scand J Gastroenterol 2004;39(9):846-851
8. Kewenter J, Bjork S, Haglind E et al. Screening and rescreening for colorectal cancer. A controlled trial of fecal occult blood testing in 27,700 subjects. Cancer 1988;62(3):645-651
9. Arveux P, Durand G, Milan C et al. Views of a general population on mass screening for colorectal cancer: the Burgundy Study. Prev Med 1992;21(5):574-581
10. Weissfeld JL, Schoen RE, Pinsky PF et al. Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial. J Natl Cancer Inst 2005;97(13):989-997
11. Segnan N, Senore C, Andreoni B et al. Baseline findings of the Italian multicenter randomized controlled trial of once-only sigmoidoscopy- SCORE. J Natl Cancer Inst 2002;94(23):1763-1772
12. UK Flexible Sigmoidoscopy Screening Trial Investigators. Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 2002;359(9314):1291-1300
13. Gondal G, Grotmol T, Hofstad B et al. The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years. Scand J Gastroenterol 2003;38(6):635-642
14. Thomas W, White CM, Mah J et al. Longitudinal compliance with annual screening for fecal occult blood. Minnesota Colon Cancer Control Study. Am J Epidemiol 1995;142(2):176-182
15. Lindholm E, Brevinge H, Haglind E. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg 2008;95(8):1029-1036
16. Hewitson P, Glasziou P, Watson E et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008;103(6):1541-1549
17. Hoff G, Grotmol T, Skovlund E et al. Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial. BMJ 2009;338:b1846.
18. Winawer S, Fletcher R, Rex D et al. Colorectal cancer screening and surveillance: clinical guidelines and rationale-update based on new evidence. Gastroenterology 2003;124:544-560
19. The Council of The European Union. Council Recommendation of 2 December 2003 on cancer screening. 2003/878/EC. Official J Eur Union 2003;34-38
20. International Cancer Screening Network. . cancer.gov/icsn/meetings/2008/ ICSN2008-colorectal.pdf (5 August 2008, date last accessed).
21. Danish National Board of Health. planlaegning-og-behandling/planer- indsatser/kraeft/ kraeftstyregruppe/referat%20ksg%202008.05.30%20final.pdf (5 August 2008, date last accessed).
22. Kronborg O, Fenger C, Søndergaard O et al. Initial mass screening for colorectal cancer with fecal occult blood test. Scand J Gastroenterol 1987;22:677-686
23. Neilson AR, Whynes DK. Determinants of persistent compliance with screening for colorectal cancer. Soc Sci Med 1995;41(3):365-374
24. Meissner HI, Breen N, Klabunde CN et al. Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev 2006;15(2):389-394
25. Young WF, McGloin J, Zittleman L et al. Predictors of colorectal screening in rural Colorado: testing to prevent colon cancer in the high plains research network. J Rural Health 2007;23(3):238-245
26. Greiner KA, James AS, Born W et al. Predictors of fecal occult blood test (FOBT) completion among low-income adults. Prev Med 2005;41(2):676-684
27. Coughlin SS, Thompson TD, Seeff L et al. Breast, cervical, and colorectal carcinoma screening in a demographically defined region of the southern U.S. Cancer 2002;95(10):2211-2222
28. Thompson B, Coronado G, Neuhouser M et al. Colorectal carcinoma screening among Hispanics and non-Hispanic whites in a rural setting. Cancer 2005;103(12):2491-2498
29. Walsh JM, Kaplan CP, Nguyen B et al. Barriers to colorectal cancer screening in Latino and Vietnamese Americans. Compared with non-Latino white Americans. J Gen Intern Med 2004;19(2):156-166
30. Sewitch MJ, Fournier C, Ciampi A et al. Adherence to colorectal cancer screening guidelines in Canada. BMC Gastroenterol 2007;7:39.
31. Shapiro JA, Seeff LC, Nadel MR. Colorectal cancer-screening tests and associated health behaviors. Am J Prev Med 2001;21(2):132-137
32. Lynge E, Olsen AH, Fracheboud J et al. Reporting of performance indicators of mammography screening in Europe. Eur J Cancer Prev 2003;12:213-222
33. NHS Breast Screening Programme Publications: Annual Reviews and Leaflets. publications/reviews-leaflets.html#ar (12 May 2009, date last accessed).
34. Whynes DK, Frew EJ, Manghan CM et al. Colorectal cancer, screening and survival: the influence of socio-economic deprivation. Public Health 2003;117(6):389-395
35. Du XL, Fang S, Vernon SW et al. Racial disparities and socioeconomic status in association with survival in a large population-based cohort of elderly patients with colon cancer. Cancer 2007;110(3):660-669
36. Hole DJ, McArdle CS. Impact of socioeconomic deprivation on outcome after surgery for colorectal cancer. Br J Surg 2002;89(5):586-590
37. Aldridge ML, Daniels JL, Jukic AM. Mammograms and Healthcare Access Among US Hispanic and Non-Hispanic 40 Years and Older. Fam Community Health 2006;29:80-88
38. Barr JK, Franks AL, Lee NC et al. Factors associated with continued participation in mammography screening. Prev Med 2001;33:661-667
39. von Euler-Chelpin M, Olsen AH, Njor S et al. Socio-demographic determinants of participation in mammography screening. Int J Cancer 2008;122(2):418-423
40. Farrands PA, Hardcastle JD, Chamberlain J et al. Factors affecting compliance with screening for colorectal cancer. Community Med 1984;6(1):12-19
41. Jorgensen OD, Kronborg O, Fenger C. A randomised study of screening for colorectal cancer using faecal occult blood testing: results after 13 years and seven biennial screening rounds. Gut 2002;50(1):29-32.
42. Segnan N, Senore C, Andreoni B et al. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates. J Natl Cancer Inst 2005;97(5):347- 57.
43. Malila N, Olivanen T, Hakama M. Implementation of colorectal cancer screening in Finland: experiences from the first three years of a public health programme. Z Gastroenterol 2007;45:1-4.
44. Faivre J, Dancourt V, Lejeune C et al. Reduction in colorectal cancer mortality by fecal occult blood screening in a French controlled study. Gastroenterology 2004;126(7):1674-1680
45. Hart AR, Glover N, Howick-Baker J et al. An industry based approach to colorectal cancer screening in an asymptomatic population. Postgrad Med J 2003;79(937):646-649
46. Steele RJC, Parker R, Patnick J et al. A demonstration pilot trial for colorectal cancer screening in the United Kingdom: a new concept in the introduction of healthcare strategies. J Med Screen 2001;8:197-203.
47. Weller D, Coleman D, Robertson R et al. The UK colorectal cancer screening pilot: results of the second round of screening in England. Br J Cancer 2007;97(12):1601-1605
48. Bowel Cancer Screening Pilot Monitoring and Evaluation Steering Committee. The Australian Bowel Cancer Screening Pilot Program and Beyond: The Final Evaluation, 2005.
49. Denis B, Ruetsch M, Strentz P et al. Short term outcomes of the first round of a pilot colorectal cancer screening programme with guaiac based faecal occult blood test. Gut 2007;56(11):1579-1584
50. Gennemførlighedsundersøgelse af screening for tarmkræft I Københavns Amt. Copenhagen: Region Hovedstaden, Kræftens Bekæmpelse, 2007.
51. Screening for tarmkræft i Vejle Amt-en gennemfø rlighedsundersøgelse august 2005-november 2006. Vejle: Vejle Sygehus, Region Syddanmark, 2007.
52. Thorpe LE, Mostashari F, Hajat A et al. Colon cancer screening practices in New York City, 2003: results of a large random-digit dialed telephone survey. Cancer 2005;104(5):1075-1082
53. Janz NK, Wren PA, Schottenfeld D et al. Colorectal cancer screening attitudes and behavior: a population-based study. Prev Med 2003;37:627-634
54. Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ 2004; 329(7458):133.